Dystrophin acts as a transplantation rejection antigen in dystrophin- deficient mice: Implication for gene therapy

Journal of Immunology

Volumn 160, Issue 9, 1998, Pages 4635-4640

  Ohtsuka, Yoshikazu ^a,c   Udaka, Keiko ^b   Yamashiro, Yuichiro ^a   Yagita, Hideo ^a   Okumura, Ko ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; DYSTROPHIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL TRANSPLANTATION; GENE EXPRESSION; GENE THERAPY; GRAFT REJECTION; HEREDITARY SPINAL MUSCULAR ATROPHY; IMMUNE DEFICIENCY; IMMUNOBLOTTING; IMMUNOLOGICAL TOLERANCE; MALE; MOUSE; MUSCLE FIBRIL; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

AMINO ACID SEQUENCE; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL TRANSPLANTATION; CYTOTOXICITY, IMMUNOLOGIC; DYSTROPHIN; GENE THERAPY; GRAFT SURVIVAL; MALE; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; PEPTIDES; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS;

EID: 0032080573     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Hoffman, E. P., R. H. Brown, and L. M. Kunkel. 1987. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51:919.
2. Hoffman, E. P., A. P. Monaco, C. C. Feener, and L. M. Kunkel. 1987. Conservation of the Duchenne muscular dystrophy gene in mice and humans. Science 238:347.
3. Zuhrzvcka-Gaarn, E. E., D. E. Bulman, G. Karpati, A. H. M. Burghes, B. Belfall, H. J. Klamut, J. Talbot, R. S. Hodges, P. N. Ray, and R. G. Worton. 1988. The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle. Nature 333:466.
4. Campbell, K. P., and S. D. Kahl. 1989. Association of dystrophin and an integral membrane glycoprotein. Nature 338:259.
5. Koenig, M., E. P. Hoffman, C. J. Bertelson, A. P. Monaco, C. Feener, and L. M. Kunkel. 1987. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50:509.
6. Partridge, T. A., J. E. Morgan, G. R. Coulton, E. P. Hoffman, and E. M. Kunkel. 1989. Conversion of mdx myofibers from dystrophin-negative to -positive by injection of normal myoblasts. Nature 337:176.
7. Huard, J., J. P. Bouchard, R. Roy, F. Malouin, G. Dansereau, C. Labrecque, N. Albert, C. L. Richards, B. Lemieux, and J. P. Tremblay. 1992. Human myoblast transplantation: preliminary results of 4 cases. Muscle Nerve 15:550.
8. Gussoni, E., G. K. Pavlath, A. M. Lanctot, K. R. Sharma, R. G. Miller, L. Steinman, and H. M. Blau. 1992. Normal dystrophin transcripts detection in Duchenne muscular dystrophy patients after myoblast transplantation. Nature 356:435.
9. Karpati, G., D. Ajdukovic, D. Arnold, R. B. Gledhill, R. Guttmann, P. Holland, P. A. Koch, E. Shoubridge, D. Spence, M. Vanasse, G. V. Watters, M. Abrahamowicz, C. Duff, and R. G. Worton. 1993. Myoblast transfer in Duchenne muscular dystrophy. Ann. Neural. 34:8.
10. Bulfield, G., W. G. Siller, P. A. L. Wright, and K. J. Moore. 1984. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc. Natl. Acad. Sci. USA 81:1189.
11. Cox, G. A., N. M. Cole, K. Matsumura, S. F. Phelps, S. D. Hauschka, K. P. Campbell, J. A. Faulkner, and J. S. Chamberlain. 1993. Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity. Nature 364:725.
12. Ragot, T., N. Vincent, P. Chafey, E. Vigne, H. Gilgenkrantz, D. Couton, J. Carlaud, P. Briand. J.-C. Kaplan, M. Perricaudet, and A. Kahn. 1993. Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature 361:647.
13. Watt, D. J., J. Karasinski, and M. A. England. 1993. Migration of lacZ positive cells from the tibialis anterior to the extensor digitorum longus muscle of the X-linked muscular dystrophic (mdx) mouse. J. Muscle Res. Cell Motil. 14:121.
14. Rammensee, H.-G., K. Falk, and O. Rotzschke. 1993. Peptides naturally presented by MHC class I molecules. Annu. Rev. Immunol. 11:213.
15. Udaka, K., K.-H. Wiesmuller, S. Kienle, G. Jung, and P. Walden. 1995. Decrypting the structure of MHC-I-restricted CTE epitopes with complex peptide libraries. J. Exp. Med. 181:2097.
16. Rammensee, H.-G., T. Friede, and S. Stevanovic. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics 41:178.
17. Watt, D. J., K. Lambert, J. E. Morgan, T. A. Partridge, and J. C. Sloper. 1982. Incorporation of donor muscle precursor cells into an area of muscle regeneration in the host mouse. J. Neurosci. 57:319.
18. Morgan, J. E., D. J. Watt, J. C. Sloper, and T. A. Partridge. 1988. Partial correction of an inherited biochemical defect of skeletal muscle by grafts of normal muscle precursor cells. J. Neurosci. 86:137.
19. England, S. B., L. V. B. Nicholson, M. A. Johnson, S. M. Forrest, D. R. Love, E. E. Zubrzycka-Gaarn, D. E. Bulman, J. B. Harris, and K. E. Davies. 1990. Very mild muscular dystrophy associated with the deletion of 46% of dystrophin. Nature 343:180.
20. b and ovalbumin process the same peptide, SIINFEKL. Cell. Immunol 150:447.
21. Guerette, B., I. Asselin, J. T. Vilquin, R. Roy, and J. P. Tremblay. 1995. Lymphocyte infiltration following allo- and xenomyoblast transplantation in mdx mice. Muscle Nerve 18:39.
22. Kaufman, D. L., M. Clare-Salzer, J. Tian, T. Forsthuber, G. S. P. Ting, P. Robinson, M. A. Atkinson, E. E. Sercarz, A. J. Tobin, and P. V. Lehmann. 1993. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366:69.
23. Aichele, P., D. Kyburz, P. S. Ohashi, B. Odermatt, R. M. Zinkernagel, H. Nengartner, and H. Pircher. 1994. Peptide-induced T-cell tolerance to prevent autoimmune diabetes in a transgenic mouse model. Proc. Natl. Acad. Sci. USA 91:444.
24. Aichele, P., K. Brduscha-Riem, R. M. Zinkernagel, H. Hengartner, and H. Pircher. 1995. T cell priming versus T cell tolerance induced by synthetic peptides. J. Exp. Med. 182:261.
25. Toes, R. E. M., R. Offringa, R. J. J. Blom, C. J. M. Melief, and W. M. Kast. 1996. Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction. Proc. Natl. Acad. Sci. USA 93:7855.
26. Toes, R. E. M., R. J. J. Blom, R. Offringa, W. M. Kast, and C. J. M. Melief. 1996. Enhanced tumor outgrowth after peptide vaccination. J. Immunol. 156:3911.
27. Bashuda, H., K. Takazawa, T. Tamatani, M. Miyasaka, H. Yagita, and K. Okumura. 1996. Induction of persistent allograft tolerance in the rat by combined treatment with anti-leukocyte function-associated antigen-1 and anti-intercellular adhesion molecule-1 monoclonal antibodies, donor-specific transfusion, and FK506. Transplantation 62:117.
28. Gotoh, M., T. Fukuzaki, M. Monden, K. Dono, T. Kanai, H. Yagita, K. Okumura, and T. Mori. 1994. A potential immunosuppressive effect of anti-lymphocyte function-associated antigen-1 monoclonal antibody on islet transplantation. Transplantation 57:123.
29. Balisa, P., K. D. Chavin, L. Qin, J. Woodward, J. Lin, P. S. Linsley, and J. S. Bromberg. 1994. CTLA4Ig prolongs allograft survival while suppressing cell-mediated immunity. Transplantation 58:1082.
30. Russell, M. E., W. W. Hancock, E. Akalin, A. F. Wallace, T. Glysing-Jensen, T. A. Willett, and M. H. Sayegh. 1996. Chronic cardiac rejection in the LEW to F344 rat model: blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis. J. Clin. Invest. 97:833.
31. Vincent, N., T. Ragot, H. Gilgenkrantz, D. Couton, P. Chafey, A. Gregoire, P. Briand, J.-C. Kaplan, A. Kahn, and M. Perricaudet. 1993. Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene. Nat. Genet. 5:130.
32. Deconinck, N., T. Ragot, G. Marechal, M. Perricaudet, and J. M. Gillis. 1996. Functional protection of dystrophic mouse (mdx) muscles after adenovirus-mediated transfer of a dystrophin minigene. Proc. Natl. Acad. Sci. USA 93:3570.
33. Yang, Y., H. C. J. Ertl, and J. M. Wilson. 1994. MHC class-I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with El-deleted recombinant adenoviruses. Immunity 1:433.
34. Yang, Y., F. A. Nunes, K. Berencsi, E. E. Furth, E. Gonczol, and J. M. Wilson. 1994. Cellular immunity to viral antigens limits El-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91:4407.
35. Engelhardt, J. F., X. Ye, B. Doranz, and J. M. Wilson. 1994. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. USA 91:6196.
36. Kay, M. A., A.-X. Holterman, L. Meuse, A. Gown, H. D. Ochs, P. S. Linsley, and C. B. Wilson. 1995. Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration. Nat. Genet. 11:191.
37. Dai, Y., E. M. Schwarz, D. Gu, W.-W. Zhang, N. Sarvetnick, and I. M. Verma. 1995. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc. Natl. Acad. Sci. USA 92:1401.
38. Tripathy, S. K., H. B. Black, E. Goldeasser, and J. M. Leiden. 1996. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat. Med. 2:545.
39. Giannelli, F., K. H. Choo, D. J. G. Rees, Y. Boyd, C. R. Rizza, and G. G. Brownlee. 1983. Gene deletions in patients with haemophilia B and anti-factor IX antibodies. Nature 303:181.
40. Ulmer, J. B., J. J. Donnelly, S. E. Parker, G. H. Rhodes, P. L. Feigner, V. J. Dwarki, S. H. Gromkowki, R. R. Deck, C. M. DeWitt, A. Friedman, L. A. Hawe, K. R. Leander, D. Marinez, H. C. Perry, J. W. Shiver, D. L. Montgomery, and M. A. Liu. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745.
41. Wang, B., K. E. Ugen, V. Srikantan, M. G. Agadjanyan, K. Dang, Y. Refaeli, A. Sato, J. Boyer, W. V. Williams, and D. B. Weiner. 1993. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 90:4156.
42. Hohlfeld, R., and A. G. Engel. 1994. The immunology of muscle. Immunol. Today 15:269.
43. Pardoll, D. M., and A. M. Beckerleg. 1995. Exposing the immunology of naked DNA vaccines. Immunity 3:165.